Search results
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 5 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 10 hours agodifferent mutation. The KRAS gene is typically the first to mutate in the cascade of genetic changes...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 21 hours agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
Early Stage Prostate Cancer Symptoms and Detection
Healthline· 7 days agoEarly stage prostate cancer usually doesn’t have symptoms. Prostate cancer is typically a slow-growing cancer. It starts in the prostate ...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 5 days agoALK is a gene that is “switched off” in the womb but can turn back on for some people and cause ...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters via AOL· 5 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
What is the healthiest fruit? The No. 1 pick, according to a dietitian
TODAY via Yahoo News· 1 hour agoWhat is the healthiest fruit? Blueberries top the list of healthiest fruits for weight loss, heart...
With new Enhertu data, an ADC could overtake chemo in breast cancer
BioPharma Dive via Yahoo Finance· 3 days agoLayman also didn’t take part in the trial, but is an investigator in a different Enhertu study....
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 3 days agoThe approach isn’t entirely new: The first antibody drug conjugate was approved by the Food and Drug...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 2 days agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...